On May 13, 2020, the Patent Trial and Appeal Board (“Board”) issued a decision in Ex parte Ismagilov reversing an Examiner’s rejection of original claims for
Read more
Obviousness-type double patenting (“ODP”) is a judicially-created doctrine designed to prevent a party from extending its right to exclude by enforcing claims in a later-filed patent that are
Read more
During patent examination, examiners must give claim terms “their broadest reasonable interpretation consistent with the specification.” MPEP 2111. The Patent Trial and Appeal Board (“Board”) emphasized
Read more
On June 9, 2020, the Patent Trial and Appeal Board (“Board”) ­reversed the Examiner’s obviousness rejections in Ex parte Leibold. The obviousness rejections were based on
Read more
Ex parte Batteux is a 2007 decision of the Board of Patent Appeals and Interferences (BPAI) that is listed among the Patent Trial and Appeal Board’s
Read more
Under the doctrine of “claim preclusion” (res judicata), a judgment on the merits in a prior suit bars a second suit involving the same parties or
Read more
On April 29, 2020, the Patent Trial and Appeal Board (“Board”) issued a decision in Ex parte Martin reversing, inter alia, an Examiner’s rejection of a
Read more
Section 2144.04(IV)(C) of the Manual of Patent Examining Procedure describes legal precedents relating to “Changes in [the] Sequence of Adding Ingredients” and cites to In re
Read more
On March 20, 2020, the Patent Trial and Appeal Board (“Board”) issued a decision in Ex parte Ferreyro reversing, inter alia, an Examiner’s rejection of a claim directed to a device comprising an injection part “having
Read more
On April 27, 2020, the Patent Trial and Appeal Board (“Board”) issued a decision in Ex parte Nagai reversing an Examiner’s obviousness rejection premised on a
Read more